Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: Larimar Therapeutics Inc., 3 years.
Larimar Therapeutics Inc.
Director
Spero Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 23, 2026 | Spero Therapeutics Inc. | Grant or award | +10,000 | — | — |
| Feb 27, 2026 | Larimar Therapeutics Inc. | Open-market purchase | +5,000 | $5.00 | $25,000 |
| Jun 12, 2025 | Spero Therapeutics Inc. | Grant or award | +20,000 | — | — |
| May 29, 2024 | Spero Therapeutics Inc. | Grant or award | +20,000 | — | — |
| Feb 14, 2024 | Larimar Therapeutics Inc. | Open-market purchase | +2,000 | $11.00 | $22,000 |
| Oct 5, 2023 | Spero Therapeutics Inc. | Grant or award | +20,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.